. "Antifosfolidov\u00FD syndrom, karfdi\u00E1ln\u00ED a cerebr\u00E1ln\u00ED manifestace" . . . "The main clinical criterion of antiphospholipid syndrome (APS) is venous or arterial thrombosis. Its less-know clinical manifestation is the affection of the heart and heart valves. The authors have described simultaneous involvement of the brain and within primary APS athe was manifested clinically withcerebral infarctiondeveloped due to cardiac embolization in aseptic (noninfectious) endokarditis of the mitral valve. Abnormalities of cardiac valves are found in as much as one-third of patiens with primary APS. Valvulopathy is presented by thickening, adhesions, valve rigidity and non-bacterial vegetations. However, these lesions may be evaluated by defferential diagnostics as infectious endokarditis and, thus, treated incorrectly. In aseptic endokarditis, developed at APS, anticoagulant therapy is highly effective in secondary prevention of systemic, especially cerebr\u00E1l, embolization."@en . "Cardiac and Cerebr\u00E1l Manifestations"@en . "B\u00E1rtkov\u00E1, Andrea" . "3"^^ . "1210-7859" . "Cardiac and Cerebr\u00E1l Manifestations"@en . "CZ - \u010Cesk\u00E1 republika" . . "69" . . "RIV/61989592:15110/10:10212118!RIV11-MSM-15110___" . "RIV/61989592:15110/10:10212118" . . "4"^^ . "Antifosfolidov\u00FD syndrom, karfdi\u00E1ln\u00ED a cerebr\u00E1ln\u00ED manifestace"@cs . "Antifosfolidov\u00FD syndrom, karfdi\u00E1ln\u00ED a cerebr\u00E1ln\u00ED manifestace" . "1"^^ . "Antifosfolidov\u00FD syndrom, karfdi\u00E1ln\u00ED a cerebr\u00E1ln\u00ED manifestace"@cs . "5" . . . . . "Kraj\u00ED\u010Dkov\u00E1, Dana" . "[1812B29250AC]" . "\u010Cesk\u00E1 a slovensk\u00E1 neurologie a neurochirurgie" . "Hlavn\u00EDm klinick\u00FDm krit\u00E9riem antifosfolipidov\u00E9ho syndromu (APS) je ven\u00F3zn\u00ED nebo arteri\u00E1ln\u00ED tromb\u00F3za. Jeho m\u00E9n\u011B zn\u00E1m\u00FDm klinick\u00FDm projevem je posti\u017Een\u00ED srdce a srde\u010Dn\u00EDch chlopn\u00ED. Auto\u0159i ve sv\u00E9 pr\u00E1ci popisuj\u00ED simult\u00E1nn\u00ED posti\u017Een\u00ED mozku a srdce v r\u00E1mci prim\u00E1rn\u00EDho APS, kter\u00E9 se klinicky manifestovalo cerebr\u00E1ln\u00EDm infarktem vznikl\u00FDm na z\u00E1klad\u011B kardi\u00E1ln\u00ED embolizace p\u0159i aseptick\u00E9 (neinfek\u010Dn\u00ED) endokarditid\u011B mitr\u00E1ln\u00ED chlopn\u011B.Abnormality kardi\u00E1ln\u00EDch chlopn\u00ED nal\u00E9z\u00E1me a\u017E u t\u0159etiny pacient\u016F s prim\u00E1rn\u00EDm APS. Valvulopatie je prezentov\u00E1na zten\u010Den\u00EDm, sr\u016Fsty, rigiditou chlopn\u011B a nebakteri\u00E1ln\u00EDmi vegetacemi. Tyto l\u00E9ze v\u0161ak mohou b\u00FDt diferenci\u00E1ln\u011B diagnosticky vyhodnoceny jako infek\u010Dn\u00ED endokarditida a tud\u00ED\u017E nespr\u00E1vn\u011B l\u00E9\u010Deny. U aseptick\u00E9 endokarditidy, vznikl\u00E9 p\u0159i APS, je antikoagula\u010Dn\u00ED terapie v sekund\u00E1rn\u00ED prevenci syst\u00E9mov\u00E9 embolizace, zejm\u00E9na cerebr\u00E1ln\u00ED, vysoce efektivn\u00ED." . "15110" . . "V" . "Dul\u00ED\u010Dek, Pavel" . "Hlavn\u00EDm klinick\u00FDm krit\u00E9riem antifosfolipidov\u00E9ho syndromu (APS) je ven\u00F3zn\u00ED nebo arteri\u00E1ln\u00ED tromb\u00F3za. Jeho m\u00E9n\u011B zn\u00E1m\u00FDm klinick\u00FDm projevem je posti\u017Een\u00ED srdce a srde\u010Dn\u00EDch chlopn\u00ED. Auto\u0159i ve sv\u00E9 pr\u00E1ci popisuj\u00ED simult\u00E1nn\u00ED posti\u017Een\u00ED mozku a srdce v r\u00E1mci prim\u00E1rn\u00EDho APS, kter\u00E9 se klinicky manifestovalo cerebr\u00E1ln\u00EDm infarktem vznikl\u00FDm na z\u00E1klad\u011B kardi\u00E1ln\u00ED embolizace p\u0159i aseptick\u00E9 (neinfek\u010Dn\u00ED) endokarditid\u011B mitr\u00E1ln\u00ED chlopn\u011B.Abnormality kardi\u00E1ln\u00EDch chlopn\u00ED nal\u00E9z\u00E1me a\u017E u t\u0159etiny pacient\u016F s prim\u00E1rn\u00EDm APS. Valvulopatie je prezentov\u00E1na zten\u010Den\u00EDm, sr\u016Fsty, rigiditou chlopn\u011B a nebakteri\u00E1ln\u00EDmi vegetacemi. Tyto l\u00E9ze v\u0161ak mohou b\u00FDt diferenci\u00E1ln\u011B diagnosticky vyhodnoceny jako infek\u010Dn\u00ED endokarditida a tud\u00ED\u017E nespr\u00E1vn\u011B l\u00E9\u010Deny. U aseptick\u00E9 endokarditidy, vznikl\u00E9 p\u0159i APS, je antikoagula\u010Dn\u00ED terapie v sekund\u00E1rn\u00ED prevenci syst\u00E9mov\u00E9 embolizace, zejm\u00E9na cerebr\u00E1ln\u00ED, vysoce efektivn\u00ED."@cs . "247110" . . "Manifestations; Cerebr\u00E1l; Cardiac"@en . . .